Focus: Kuros Biosciences is a Swiss-based medical devices company specializing in bone regeneration and orthopedic solutions, operating at the public company stage since 2008.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Best suited for regulatory or manufacturing specialists seeking stability at a niche public medtech firm; limited growth prospects for ambitious early-career professionals.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship product with 2 active trials establishing clinical utility in orthopedic reconstruction.
Help build intelligence for Kuros Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Kuros Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Product variant expanding MagnetOs platform into spinal degenerative disease market.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles